Clincosm LogoSign in Get a demo

Triple Negative Breast Cancer

Showing NaN - NaN of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer Trial in United States (Cisplatin, Paclitaxel)

Active, not recruiting
Has Results
  • Triple Negative Breast Cancer
  • Birmingham, Alabama
  • +19 more
Feb 14, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Advanced Solid Tumor, Advanced Cancer, Triple Negative Breast Cancer Trial in Nashville, Houston, San Antonio (NBE-002)

Recruiting
  • Advanced Solid Tumor
  • +2 more
  • Nashville, Tennessee
  • +2 more
Mar 3, 2022

Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)

Recruiting
  • Advanced Cancer
  • +9 more
  • COM701
  • COM701 with Opdivo (Nivolumab).
  • Los Angeles, California
  • +10 more
Jan 25, 2022

Colorectal Cancer Metastatic, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in Canada, United States (EDP1503,

Completed
  • Colorectal Cancer Metastatic
  • +6 more
  • EDP1503
  • Pembrolizumab
  • Rogers, Arkansas
  • +7 more
Nov 11, 2021

Advanced Solid Tumors, Metastatic Colon Cancer, Metastatic Breast Cancer Trial in United States (Fruquintinib (HMPL-013))

Recruiting
  • Advanced Solid Tumors
  • +6 more
  • Fruquintinib (HMPL-013)
  • Phoenix, Arizona
  • +8 more
Aug 30, 2021

Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

Completed
Has Results
  • Gastric Adenocarcinoma
  • +15 more
  • Sacituzumab Govitecan-hziy (SG)
  • Aurora, Colorado
  • +11 more
Aug 10, 2021

Triple Negative Breast Cancer Trial in Worldwide (Cyclophosphamide, Placebo, Doxorubicin)

Completed
  • Triple Negative Breast Cancer
  • Scottsdale, Arizona
  • +157 more
Jan 15, 2021

Advanced Ovarian Cancer, Triple Negative Breast Cancer Trial in Worldwide (Atezolizumab, RO6870810)

Terminated
  • Advanced Ovarian Cancer
  • Triple Negative Breast Cancer
  • Boston, Massachusetts
  • +10 more
Nov 5, 2020

Solid Tumor, Non Small Cell Lung Cancer, Renal Cell Carcinoma Trial in Worldwide (LY3381916, LY3300054)

Terminated
  • Solid Tumor
  • +3 more
  • Indianapolis, Indiana
  • +11 more
Jun 8, 2020

Cancer of the Breast, Breast Cancer, Advanced Breast Cancer Trial in United States (Seviteronel)

Completed
  • Cancer of the Breast
  • +6 more
  • Birmingham, Alabama
  • +35 more
Jan 31, 2019

Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer Trial in United States (Abraxane alone, Abraxane +

Completed
Has Results
  • Breast Cancer
  • +3 more
  • Abraxane alone
  • Abraxane + Tigatuzumab
  • Birmingham, Alabama
  • +9 more
Oct 24, 2017

Estrogen Receptor Negative Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Triple Negative Breast

Terminated
Has Results
  • Estrogen Receptor Negative Breast Cancer
  • +5 more
  • Birmingham, Alabama
  • +15 more
May 22, 2017

Triple Negative Breast Cancer Trial in Nashville (NK012)

Completed
  • Triple Negative Breast Cancer
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Feb 12, 2015